Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 26 tables and 58 figures, this 126-page report North America Connected Healthcare Device Market 2023-2033 by Product ...

Advanced sensing features are coming to wearables beginning in 2025 and Penn State’s device, made with laser-modified ...

The global biosensors market was valued at $26.75 billion in 2022 and is projected to reach $45.95 billion by 2030. This ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

HealthDay News — The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

Continuous glucose monitors, or CGMs, are devices that track blood sugar in real-time and can tell wearers how their bodies ...

The American Diabetes Association (ADA) recommends that, for ideal use and implementation, anyone prescribed continuous glucose monitoring should receive robust education, training, and support and ...